Global Care Access
Advanced Treatment Discovery
For patients told their options are limited, or researching a therapy that may not be accessible where they live. CrossCare shows where relevant programmes exist and what would need to be true for you to be considered — never whether a treatment will work.
Pathways
CAR-T & Cellular Therapy
Country-specific availabilityEngineered immune-cell therapies used in selected blood cancers, with eligibility decided by the treating haematology team.
Approved indications differ by country. Some programmes are only accessible inside a clinical trial.
Where relevant programmes exist
Listing a country here means relevant programmes are known to exist there. It is not a statement that you are eligible, that the therapy is approved for your indication, or that it will help.
Ask about CAR-T & Cellular Therapy
Healthcare decisions should be based on clinical appropriateness — not price alone. CrossCare helps patients understand their options, but diagnosis and treatment recommendations must come from qualified healthcare professionals. CrossCare never states that a treatment is a cure, and never promises trial enrolment or access. Back to Global Care Access